
June 3 (Reuters) - Evolent Health Inc EVH.N:
REAFFIRMS 2025 REVENUE GUIDANCE OF $2.06 BILLION TO $2.11 BILLION - SEC FILING
REAFFIRMS Q2 2025 REVENUE GUIDANCE OF $440 MILLION TO $470 MILLION - SEC FILING
FY2025 REVENUE VIEW $2.05 BILLION -- LSEG IBES DATA
Q2 REVENUE VIEW $459.4 MILLION -- LSEG IBES DATA
Source text: [ID:n0001628908-25-000069]
Further company coverage: EVH.N